The levels of CXCL4 and CXCL12 can be further elevated in cancer patients53,54 leading to micromolar concentrations at the tumor or metastasis site that could favor CXCL4–CXCL12 heterodimerization in vivo. The gene discussed is PF4; the disease is cancer.